Majhail Navneet S, Lichtin Alan E
Department of Internal Medicine, The Cleveland Clinic Foundation, OH 44195, USA.
Cleve Clin J Med. 2003 May;70(5):466-70. doi: 10.3949/ccjm.70.5.466.
Although the antiplatelet agent clopidogrel is associated with an increased incidence of thrombotic thrombocytopenic purpura (TTP), available evidence is not sufficient to establish or disprove a causal relationship. We review and assess the evidence and case reports linking clopidogrel use with TTP and discuss how to approach the risk of TTP in patients taking clopidogrel.
